Lozano, Daniel <br/><br/>
Osteostatin improves the osteogenic activity of fibroblast growth factor-2 immobilized in Si-doped hydroxyapatite in osteoblastic cells.  [electronic resource] 

 -  Acta biomaterialia  Jul 2012 
 - 2770-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1878-7568 
<br/><br/><label>Standard No.: </label>10.1016/j.actbio.2012.04.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Alkaline Phosphatase--metabolism<br/>Animals<br/>Antibodies, Neutralizing--pharmacology<br/>Biocompatible Materials--pharmacology<br/>Calcification, Physiologic--drug effects<br/>Cell Line<br/>Cell Proliferation--drug effects<br/>Culture Media, Conditioned--pharmacology<br/>Durapatite--pharmacology<br/>Fibroblast Growth Factor 2--pharmacology<br/>Gene Expression Regulation--drug effects<br/>Humans<br/>Immobilized Proteins--pharmacology<br/>Mice<br/>Osteoblasts--drug effects<br/>Osteogenesis--drug effects<br/>Parathyroid Hormone-Related Protein--pharmacology<br/>Peptide Fragments--pharmacology<br/>Sus scrofa<br/>Vascular Endothelial Growth Factor A--genetics<br/>Vascular Endothelial Growth Factor Receptor-1--genetics<br/>Vascular Endothelial Growth Factor Receptor-2--genetics